VitruvianMD

VitruvianMD is a pioneering South African medical technology company that is transforming healthcare diagnostics across Africa through innovative AI-powered solutions. Founded in 2020, the company combines biomedical engineering with cutting-edge artificial intelligence to develop affordable, accessible diagnostic assistance tools for medical laboratories. At the core of their innovation is a versatile camera system that can be seamlessly integrated with any analogue microscope, instantly digitising it and enabling advanced AI-driven diagnostic capabilities.

The company addresses one of Africa’s most critical healthcare challenges: the severe shortage of diagnostic pathologists. With Sub-Saharan Africa having only one pathologist per one million people—a tenth of the World Health Organization’s recommended level—VitruvianMD’s technology democratises access to high-quality diagnostic services. Their AI-powered platform facilitates seamless collaboration among medical experts across geographical boundaries, reducing life-threatening diagnostic delays while enhancing accuracy, consistency, and speed in medical diagnoses.

VitruvianMD’s impact spans multiple medical fields, including haematology for white blood cell differentiation, histopathology for cervical cancer screening, and reproductive health with their groundbreaking VisionMD technology for AI-driven sperm quality assessment. The company has secured $1.25 million in funding led by 27four’s Nebula Fund and is actively expanding partnerships with medical institutions, IVF clinics, and pathology laboratories across Africa and globally, working towards making state-of-the-art diagnostic care accessible to all, regardless of income or geographical limitations.